SOOKSAI KAEWBUA: Open Payments
NPI 1366962599 · MOUNT STERLING, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 41 payments from 12 companies in 2025. Trend: 2023 $936 · 2024 $797 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $436 |
| Axsome Therapeutics, Inc. | 2 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $126 |
| Alkermes, Inc. | 1 | $116 |
| Vanda Pharmaceuticals Inc. | 1 | $107 |
| Neurocrine BioSciences, Inc. | 1 | $105 |
| Lundbeck LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
Products named: REXULTI, Auvelity, CAPLYTA, LYBALVI, FANAPT, INGREZZA, AUSTEDO XR, FARXIGA.
Industry payments across KY — which companies pay providers there.
